U.S. Markets close in 3 hrs 48 mins
  • S&P 500

    3,663.58
    +1.13 (+0.03%)
     
  • Dow 30

    29,791.70
    -32.22 (-0.11%)
     
  • Nasdaq

    12,350.37
    -4.73 (-0.04%)
     
  • Russell 2000

    1,828.86
    -7.18 (-0.39%)
     
  • Crude Oil

    45.64
    +1.09 (+2.45%)
     
  • Gold

    1,829.20
    +10.30 (+0.57%)
     
  • Silver

    24.04
    -0.05 (-0.21%)
     
  • EUR/USD

    1.2096
    +0.0018 (+0.1452%)
     
  • 10-Yr Bond

    0.9530
    +0.0190 (+2.03%)
     
  • Vix

    20.69
    -0.08 (-0.39%)
     
  • GBP/USD

    1.3352
    -0.0071 (-0.5274%)
     
  • USD/JPY

    104.5030
    +0.1870 (+0.1793%)
     
  • BTC-USD

    18,855.86
    -138.04 (-0.73%)
     
  • CMC Crypto 200

    369.51
    +4.59 (+1.26%)
     
  • FTSE 100

    6,463.39
    +78.66 (+1.23%)
     
  • Nikkei 225

    26,800.98
    +13.44 (+0.05%)
     

Zacks.com featured highlights include: Daqo, Surface Oncology, Covenant, Herc and Castle Biosciences

Zacks Equity Research
·5 min read

For Immediate Release

Chicago, IL – October 19, 2020 - Stocks in this week’s article are Daqo New Energy Corp. DQ, Surface Oncology Inc. SURF, Covenant Logistics Group Inc. CVLG, Herc Holdings Inc. HRI and Castle Biosciences Inc. CSTL.

5 Stocks with Recent Price Strength to Maximize Your Gains

After the turmoil in September, Wall Street has recovered some of the lost ground so far in October. However, we are not out of the woods. Three major factors are present that can flare up market volatility anytime.

First, the U.S. Congress is yet to reach an amicable solution regarding the size and scope of the second round of the coronavirus-aid package. The Democrats have settled for a $2.2 trillion stimulus while the White House has approved only $1.8 trillion. It is not clear whether a deal will arrive before the U.S. presidential election scheduled on Nov 3.

Second, it seems a remote possibility that a vaccine or a proper line of treatment for COVID-19 will appear this year. This week the FDA has paused late-stage clinical trials of two drugs for the potential treatment of coronavirus on safety concerns.

Meanwhile, several states and regions in the United States and major Eurozone countries have recently witnessed another spike in COVID-19 infections as these economies are trying to return to normalcy.

Third, the U.S. presidential election is less than three weeks away. Historically, stock markets have remained volatile in the month before the election. Market participants generally choose to hold cash instead of investing in risky assets like equities while assessing the economic and financial consequences of the election result.

At this stage, wouldn’t it be a safer strategy to look for stocks that are winners and have the potential to gain further?

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/625382/5-stocks-with-recent-price-strength-to-maximize-your-gains

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: www.Zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
DAQO New Energy Corp. (DQ) : Free Stock Analysis Report
 
Herc Holdings Inc. (HRI) : Free Stock Analysis Report
 
Surface Oncology, Inc. (SURF) : Free Stock Analysis Report
 
Castle Biosciences, Inc. (CSTL) : Free Stock Analysis Report
 
Covenant Transportation Group, Inc. (CVLG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research